MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells

OBJECTIVE: To investigate the expression of miR-29b-3p in tissues and cells of non-small-cell lung cancer (NSCLC) and its effect on cisplatin resistance in NSCLC cells and its mechanism. METHODS: The mRNA expression of miR-29b-3p and COL1A1 in NSCLC tissue, cell line A549 and cisplatin-resistant cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Rui, Wang, Changli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170551/
https://www.ncbi.nlm.nih.gov/pubmed/32368137
http://dx.doi.org/10.2147/CMAR.S246625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170551/
https://www.ncbi.nlm.nih.gov/pubmed/32368137
http://dx.doi.org/10.2147/CMAR.S246625

Ejemplares similares